Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
October 01, 2021 08:00 ET
|
Clearmind Medicine
TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the discovery and...
Global Psychedelic Drugs Markets, 2018-2020 & 2021-2025 - Ketamine, Psilocybin, Ibogaine, LSD, Dimethyltryptamine (DMT), or MDMA
March 25, 2021 07:48 ET
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com's...
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
December 14, 2020 08:00 ET
|
Posit Science
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...
Ria Health Announces Coverage Under Anthem for Alcohol Treatment Telemedicine Program
October 21, 2019 08:30 ET
|
Ria Health
SAN FRANCISCO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Ria Health, a telehealth company providing an effective alcohol treatment program to help people reduce or stop drinking, today announced new...